Skip to main content
Journal cover image

Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.

Publication ,  Journal Article
Brodowicz, T; Ciuleanu, T; Crawford, J; Filipits, M; Fischer, JR; Georgoulias, V; Gridelli, C; Hirsch, FR; Jassem, J; Kosmidis, P; Manegold, C ...
Published in: Ann Oncol
May 2012

The current third consensus on the systemic treatment of non-small-cell lung cancer (NSCLC) builds upon and updates similar publications on the subject by the Central European Cooperative Oncology Group (CECOG), which has published such consensus statements in the years 2002 and 2005 (Zielinski CC, Beinert T, Crawford J et al. Consensus on medical treatment of non-small-cell lung cancer-update 2004. Lung Cancer 2005; 50: 129-137). The principle of all CECOG consensus is such that evidence-based recommendations for state-of-the-art treatment are given upon which all participants and authors of the manuscript have to agree (Beslija S, Bonneterre J, Burstein HJ et al. Third consensus on medical treatment of metastatic breast cancer. Ann Oncol 2009; 20 (11): 1771-1785). This is of particular importance in diseases in which treatment options depend on very particular clinical and biologic variables (Zielinski CC, Beinert T, Crawford J et al. Consensus on medical treatment of non-small-cell lung cancer-update 2004. Lung Cancer 2005; 50: 129-137; Beslija S, Bonneterre J, Burstein HJ et al. Third consensus on medical treatment of metastatic breast cancer. Ann Oncol 2009; 20 (11): 1771-1785). Since the publication of the last CECOG consensus on the medical treatment of NSCLC, a series of diagnostic tools for the characterization of biomarkers for personalized therapy for NSCLC as well as therapeutic options including adjuvant treatment, targeted therapy, and maintenance treatment have emerged and strongly influenced the field. Thus, the present third consensus was generated that not only readdresses previous disease-related issues but also expands toward recent developments in the management of NSCLC. It is the aim of the present consensus to summarize minimal quality-oriented requirements for individual patients with NSCLC in its various stages based upon levels of evidence in the light of a rapidly expanding array of individual therapeutic options.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Oncol

DOI

EISSN

1569-8041

Publication Date

May 2012

Volume

23

Issue

5

Start / End Page

1223 / 1229

Location

England

Related Subject Headings

  • Societies, Medical
  • Review Literature as Topic
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Neoadjuvant Therapy
  • Medical Oncology
  • Lung Neoplasms
  • Humans
  • Carcinoma, Non-Small-Cell Lung
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brodowicz, T., Ciuleanu, T., Crawford, J., Filipits, M., Fischer, J. R., Georgoulias, V., … Central European Cooperative Oncology Group (CECOG), . (2012). Third CECOG consensus on the systemic treatment of non-small-cell lung cancer. Ann Oncol, 23(5), 1223–1229. https://doi.org/10.1093/annonc/mdr381
Brodowicz, T., T. Ciuleanu, J. Crawford, M. Filipits, J. R. Fischer, V. Georgoulias, C. Gridelli, et al. “Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.Ann Oncol 23, no. 5 (May 2012): 1223–29. https://doi.org/10.1093/annonc/mdr381.
Brodowicz T, Ciuleanu T, Crawford J, Filipits M, Fischer JR, Georgoulias V, et al. Third CECOG consensus on the systemic treatment of non-small-cell lung cancer. Ann Oncol. 2012 May;23(5):1223–9.
Brodowicz, T., et al. “Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.Ann Oncol, vol. 23, no. 5, May 2012, pp. 1223–29. Pubmed, doi:10.1093/annonc/mdr381.
Brodowicz T, Ciuleanu T, Crawford J, Filipits M, Fischer JR, Georgoulias V, Gridelli C, Hirsch FR, Jassem J, Kosmidis P, Krzakowski M, Manegold C, Pujol JL, Stahel R, Thatcher N, Vansteenkiste J, Minichsdorfer C, Zöchbauer-Müller S, Pirker R, Zielinski CC, Central European Cooperative Oncology Group (CECOG). Third CECOG consensus on the systemic treatment of non-small-cell lung cancer. Ann Oncol. 2012 May;23(5):1223–1229.
Journal cover image

Published In

Ann Oncol

DOI

EISSN

1569-8041

Publication Date

May 2012

Volume

23

Issue

5

Start / End Page

1223 / 1229

Location

England

Related Subject Headings

  • Societies, Medical
  • Review Literature as Topic
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Neoadjuvant Therapy
  • Medical Oncology
  • Lung Neoplasms
  • Humans
  • Carcinoma, Non-Small-Cell Lung
  • 3211 Oncology and carcinogenesis